img

Global Human Low-Pass Whole Genome Sequencing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Human Low-Pass Whole Genome Sequencing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Human low-pass whole-genome sequencing is generally defined as sequencing the genome. Combined with genotype imputation, it provides an alternative to genotyping arrays for trait mapping and polygenic score calculations.
Human Low-Pass Whole Genome Sequencing report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Low-Pass Whole Genome Sequencing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Medical and Scientific Research are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Human Low-Pass Whole Genome Sequencing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Human Low-Pass Whole Genome Sequencing key companies include BGI, Breda Genetics, Azenta Life Sciences, Thermo Fisher Scientific, Psomagen, Healgen Scientific, Agilent Technologies, Macrogen and Veritas Genetics, etc. BGI, Breda Genetics, Azenta Life Sciences are top 3 players and held % share in total in 2022.
Human Low-Pass Whole Genome Sequencing can be divided into Large Human Low-Through Whole Genome Sequencing (> 5 Mb) and Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb), etc. Large Human Low-Through Whole Genome Sequencing (> 5 Mb) is the mainstream product in the market, accounting for % share globally in 2022.
Human Low-Pass Whole Genome Sequencing is widely used in various fields, such as Medical, Scientific Research and Others,, etc. Medical provides greatest supports to the Human Low-Pass Whole Genome Sequencing industry development. In 2022, global % share of Human Low-Pass Whole Genome Sequencing went into Medical filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Human Low-Pass Whole Genome Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


BGI
Breda Genetics
Azenta Life Sciences
Thermo Fisher Scientific
Psomagen
Healgen Scientific
Agilent Technologies
Macrogen
Veritas Genetics
Centogene
Nebula Genomics
CD Genomics
Segment by Type
Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb)

Segment by Application


Medical
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Human Low-Pass Whole Genome Sequencing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Human Low-Pass Whole Genome Sequencing introduction, etc. Human Low-Pass Whole Genome Sequencing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Human Low-Pass Whole Genome Sequencing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Human Low-Pass Whole Genome Sequencing
1.1 Human Low-Pass Whole Genome Sequencing Market Overview
1.1.1 Human Low-Pass Whole Genome Sequencing Product Scope
1.1.2 Human Low-Pass Whole Genome Sequencing Market Status and Outlook
1.2 Global Human Low-Pass Whole Genome Sequencing Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Human Low-Pass Whole Genome Sequencing Market Size by Region (2018-2033)
1.4 Global Human Low-Pass Whole Genome Sequencing Historic Market Size by Region (2018-2023)
1.5 Global Human Low-Pass Whole Genome Sequencing Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Human Low-Pass Whole Genome Sequencing Market Size (2018-2033)
1.6.1 North America Human Low-Pass Whole Genome Sequencing Market Size (2018-2033)
1.6.2 Europe Human Low-Pass Whole Genome Sequencing Market Size (2018-2033)
1.6.3 Asia-Pacific Human Low-Pass Whole Genome Sequencing Market Size (2018-2033)
1.6.4 Latin America Human Low-Pass Whole Genome Sequencing Market Size (2018-2033)
1.6.5 Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size (2018-2033)
2 Human Low-Pass Whole Genome Sequencing Market by Type
2.1 Introduction
2.1.1 Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
2.1.2 Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb)
2.2 Global Human Low-Pass Whole Genome Sequencing Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Human Low-Pass Whole Genome Sequencing Historic Market Size by Type (2018-2023)
2.2.2 Global Human Low-Pass Whole Genome Sequencing Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Human Low-Pass Whole Genome Sequencing Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Human Low-Pass Whole Genome Sequencing Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Human Low-Pass Whole Genome Sequencing Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Human Low-Pass Whole Genome Sequencing Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Human Low-Pass Whole Genome Sequencing Revenue Breakdown by Type (2018-2033)
3 Human Low-Pass Whole Genome Sequencing Market Overview by Application
3.1 Introduction
3.1.1 Medical
3.1.2 Scientific Research
3.1.3 Others
3.2 Global Human Low-Pass Whole Genome Sequencing Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Human Low-Pass Whole Genome Sequencing Historic Market Size by Application (2018-2023)
3.2.2 Global Human Low-Pass Whole Genome Sequencing Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Human Low-Pass Whole Genome Sequencing Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Human Low-Pass Whole Genome Sequencing Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Human Low-Pass Whole Genome Sequencing Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Human Low-Pass Whole Genome Sequencing Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Human Low-Pass Whole Genome Sequencing Revenue Breakdown by Application (2018-2033)
4 Human Low-Pass Whole Genome Sequencing Competition Analysis by Players
4.1 Global Human Low-Pass Whole Genome Sequencing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Low-Pass Whole Genome Sequencing as of 2022)
4.3 Date of Key Players Enter into Human Low-Pass Whole Genome Sequencing Market
4.4 Global Top Players Human Low-Pass Whole Genome Sequencing Headquarters and Area Served
4.5 Key Players Human Low-Pass Whole Genome Sequencing Product Solution and Service
4.6 Competitive Status
4.6.1 Human Low-Pass Whole Genome Sequencing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BGI
5.1.1 BGI Profile
5.1.2 BGI Main Business
5.1.3 BGI Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
5.1.4 BGI Human Low-Pass Whole Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.1.5 BGI Recent Developments
5.2 Breda Genetics
5.2.1 Breda Genetics Profile
5.2.2 Breda Genetics Main Business
5.2.3 Breda Genetics Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
5.2.4 Breda Genetics Human Low-Pass Whole Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.2.5 Breda Genetics Recent Developments
5.3 Azenta Life Sciences
5.3.1 Azenta Life Sciences Profile
5.3.2 Azenta Life Sciences Main Business
5.3.3 Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
5.3.4 Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific Recent Developments
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Profile
5.4.2 Thermo Fisher Scientific Main Business
5.4.3 Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific Recent Developments
5.5 Psomagen
5.5.1 Psomagen Profile
5.5.2 Psomagen Main Business
5.5.3 Psomagen Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
5.5.4 Psomagen Human Low-Pass Whole Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.5.5 Psomagen Recent Developments
5.6 Healgen Scientific
5.6.1 Healgen Scientific Profile
5.6.2 Healgen Scientific Main Business
5.6.3 Healgen Scientific Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
5.6.4 Healgen Scientific Human Low-Pass Whole Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.6.5 Healgen Scientific Recent Developments
5.7 Agilent Technologies
5.7.1 Agilent Technologies Profile
5.7.2 Agilent Technologies Main Business
5.7.3 Agilent Technologies Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
5.7.4 Agilent Technologies Human Low-Pass Whole Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.7.5 Agilent Technologies Recent Developments
5.8 Macrogen
5.8.1 Macrogen Profile
5.8.2 Macrogen Main Business
5.8.3 Macrogen Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
5.8.4 Macrogen Human Low-Pass Whole Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.8.5 Macrogen Recent Developments
5.9 Veritas Genetics
5.9.1 Veritas Genetics Profile
5.9.2 Veritas Genetics Main Business
5.9.3 Veritas Genetics Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
5.9.4 Veritas Genetics Human Low-Pass Whole Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.9.5 Veritas Genetics Recent Developments
5.10 Centogene
5.10.1 Centogene Profile
5.10.2 Centogene Main Business
5.10.3 Centogene Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
5.10.4 Centogene Human Low-Pass Whole Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.10.5 Centogene Recent Developments
5.11 Nebula Genomics
5.11.1 Nebula Genomics Profile
5.11.2 Nebula Genomics Main Business
5.11.3 Nebula Genomics Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
5.11.4 Nebula Genomics Human Low-Pass Whole Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.11.5 Nebula Genomics Recent Developments
5.12 CD Genomics
5.12.1 CD Genomics Profile
5.12.2 CD Genomics Main Business
5.12.3 CD Genomics Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
5.12.4 CD Genomics Human Low-Pass Whole Genome Sequencing Revenue (US$ Million) & (2018-2023)
5.12.5 CD Genomics Recent Developments
6 North America
6.1 North America Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Human Low-Pass Whole Genome Sequencing Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Human Low-Pass Whole Genome Sequencing Market Dynamics
11.1 Human Low-Pass Whole Genome Sequencing Industry Trends
11.2 Human Low-Pass Whole Genome Sequencing Market Drivers
11.3 Human Low-Pass Whole Genome Sequencing Market Challenges
11.4 Human Low-Pass Whole Genome Sequencing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Human Low-Pass Whole Genome Sequencing Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Human Low-Pass Whole Genome Sequencing Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Human Low-Pass Whole Genome Sequencing Market Size Share by Region (2018-2023)
Table 4. Global Human Low-Pass Whole Genome Sequencing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Human Low-Pass Whole Genome Sequencing Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Human Low-Pass Whole Genome Sequencing Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Type (2018-2023)
Table 9. Global Human Low-Pass Whole Genome Sequencing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Type (2024-2033)
Table 11. North America Human Low-Pass Whole Genome Sequencing Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Human Low-Pass Whole Genome Sequencing Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Human Low-Pass Whole Genome Sequencing Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Human Low-Pass Whole Genome Sequencing Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Human Low-Pass Whole Genome Sequencing Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Human Low-Pass Whole Genome Sequencing Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Human Low-Pass Whole Genome Sequencing Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Human Low-Pass Whole Genome Sequencing Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Human Low-Pass Whole Genome Sequencing Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Human Low-Pass Whole Genome Sequencing Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Human Low-Pass Whole Genome Sequencing Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Application (2018-2023)
Table 24. Global Human Low-Pass Whole Genome Sequencing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Application (2024-2033)
Table 26. North America Human Low-Pass Whole Genome Sequencing Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Human Low-Pass Whole Genome Sequencing Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Human Low-Pass Whole Genome Sequencing Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Human Low-Pass Whole Genome Sequencing Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Human Low-Pass Whole Genome Sequencing Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Human Low-Pass Whole Genome Sequencing Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Human Low-Pass Whole Genome Sequencing Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Human Low-Pass Whole Genome Sequencing Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Human Low-Pass Whole Genome Sequencing Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Human Low-Pass Whole Genome Sequencing Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Human Low-Pass Whole Genome Sequencing Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Low-Pass Whole Genome Sequencing as of 2022)
Table 39. Date of Key Players Enter into Human Low-Pass Whole Genome Sequencing Market
Table 40. Global Human Low-Pass Whole Genome Sequencing Key Players Headquarters and Area Served
Table 41. Human Low-Pass Whole Genome Sequencing Product Solution and Service
Table 42. Global Human Low-Pass Whole Genome Sequencing Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. BGI Basic Information List
Table 45. BGI Description and Business Overview
Table 46. BGI Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
Table 47. Revenue (US$ Million) in Human Low-Pass Whole Genome Sequencing Business of BGI (2018-2023)
Table 48. BGI Recent Developments
Table 49. Breda Genetics Basic Information List
Table 50. Breda Genetics Description and Business Overview
Table 51. Breda Genetics Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
Table 52. Revenue (US$ Million) in Human Low-Pass Whole Genome Sequencing Business of Breda Genetics (2018-2023)
Table 53. Breda Genetics Recent Developments
Table 54. Azenta Life Sciences Basic Information List
Table 55. Azenta Life Sciences Description and Business Overview
Table 56. Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
Table 57. Revenue (US$ Million) in Human Low-Pass Whole Genome Sequencing Business of Azenta Life Sciences (2018-2023)
Table 58. Azenta Life Sciences Recent Developments
Table 59. Thermo Fisher Scientific Basic Information List
Table 60. Thermo Fisher Scientific Description and Business Overview
Table 61. Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
Table 62. Revenue (US$ Million) in Human Low-Pass Whole Genome Sequencing Business of Thermo Fisher Scientific (2018-2023)
Table 63. Thermo Fisher Scientific Recent Developments
Table 64. Psomagen Basic Information List
Table 65. Psomagen Description and Business Overview
Table 66. Psomagen Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
Table 67. Revenue (US$ Million) in Human Low-Pass Whole Genome Sequencing Business of Psomagen (2018-2023)
Table 68. Psomagen Recent Developments
Table 69. Healgen Scientific Basic Information List
Table 70. Healgen Scientific Description and Business Overview
Table 71. Healgen Scientific Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
Table 72. Revenue (US$ Million) in Human Low-Pass Whole Genome Sequencing Business of Healgen Scientific (2018-2023)
Table 73. Healgen Scientific Recent Developments
Table 74. Agilent Technologies Basic Information List
Table 75. Agilent Technologies Description and Business Overview
Table 76. Agilent Technologies Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
Table 77. Revenue (US$ Million) in Human Low-Pass Whole Genome Sequencing Business of Agilent Technologies (2018-2023)
Table 78. Agilent Technologies Recent Developments
Table 79. Macrogen Basic Information List
Table 80. Macrogen Description and Business Overview
Table 81. Macrogen Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
Table 82. Revenue (US$ Million) in Human Low-Pass Whole Genome Sequencing Business of Macrogen (2018-2023)
Table 83. Macrogen Recent Developments
Table 84. Veritas Genetics Basic Information List
Table 85. Veritas Genetics Description and Business Overview
Table 86. Veritas Genetics Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
Table 87. Revenue (US$ Million) in Human Low-Pass Whole Genome Sequencing Business of Veritas Genetics (2018-2023)
Table 88. Veritas Genetics Recent Developments
Table 89. Centogene Basic Information List
Table 90. Centogene Description and Business Overview
Table 91. Centogene Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
Table 92. Revenue (US$ Million) in Human Low-Pass Whole Genome Sequencing Business of Centogene (2018-2023)
Table 93. Centogene Recent Developments
Table 94. Nebula Genomics Basic Information List
Table 95. Nebula Genomics Description and Business Overview
Table 96. Nebula Genomics Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
Table 97. Revenue (US$ Million) in Human Low-Pass Whole Genome Sequencing Business of Nebula Genomics (2018-2023)
Table 98. Nebula Genomics Recent Developments
Table 99. CD Genomics Basic Information List
Table 100. CD Genomics Description and Business Overview
Table 101. CD Genomics Human Low-Pass Whole Genome Sequencing Products, Services and Solutions
Table 102. Revenue (US$ Million) in Human Low-Pass Whole Genome Sequencing Business of CD Genomics (2018-2023)
Table 103. CD Genomics Recent Developments
Table 104. North America Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 105. North America Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 106. Europe Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 107. Europe Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 108. Asia-Pacific Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 109. Asia-Pacific Human Low-Pass Whole Genome Sequencing Market Size by Region (2018-2023) & (US$ Million)
Table 110. Asia-Pacific Human Low-Pass Whole Genome Sequencing Market Size by Region (2024-2033) & (US$ Million)
Table 111. Asia-Pacific Human Low-Pass Whole Genome Sequencing Market Share by Region (2018-2023)
Table 112. Asia-Pacific Human Low-Pass Whole Genome Sequencing Market Share by Region (2024-2033)
Table 113. Latin America Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 114. Latin America Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 115. Latin America Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 116. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 117. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 118. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 119. Human Low-Pass Whole Genome Sequencing Market Trends
Table 120. Human Low-Pass Whole Genome Sequencing Market Drivers
Table 121. Human Low-Pass Whole Genome Sequencing Market Challenges
Table 122. Human Low-Pass Whole Genome Sequencing Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Low-Pass Whole Genome Sequencing Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Human Low-Pass Whole Genome Sequencing Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Human Low-Pass Whole Genome Sequencing Market Share by Regions: 2022 VS 2033
Figure 4. Global Human Low-Pass Whole Genome Sequencing Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
Figure 11. Global Large Human Low-Through Whole Genome Sequencing (> 5 Mb) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb)
Figure 13. Global Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Human Low-Pass Whole Genome Sequencing Market Size Share by Type: 2022 & 2033
Figure 15. North America Human Low-Pass Whole Genome Sequencing Revenue Market Share by Type (2018-2033)
Figure 16. Europe Human Low-Pass Whole Genome Sequencing Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Human Low-Pass Whole Genome Sequencing Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Human Low-Pass Whole Genome Sequencing Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Human Low-Pass Whole Genome Sequencing Revenue Market Share by Type (2018-2033)
Figure 20. Medical Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Scientific Research Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Global Human Low-Pass Whole Genome Sequencing Market Size Share by Application: 2022 & 2033
Figure 24. North America Human Low-Pass Whole Genome Sequencing Revenue Market Share by Application (2018-2033)
Figure 25. Europe Human Low-Pass Whole Genome Sequencing Revenue Market Share by Application (2018-2033)
Figure 26. Asia-Pacific Human Low-Pass Whole Genome Sequencing Revenue Market Share by Application (2018-2033)
Figure 27. Latin America Human Low-Pass Whole Genome Sequencing Revenue Market Share by Application (2018-2033)
Figure 28. Middle East and Africa Human Low-Pass Whole Genome Sequencing Revenue Market Share by Application (2018-2033)
Figure 29. Human Low-Pass Whole Genome Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Human Low-Pass Whole Genome Sequencing Market Share in 2022
Figure 31. North America Human Low-Pass Whole Genome Sequencing Market Share by Country (2018-2033)
Figure 32. United States Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 33. Canada Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 34. Germany Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 35. France Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 36. U.K. Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 37. Italy Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 38. Russia Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 39. Nordic Countries Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 40. Asia-Pacific Human Low-Pass Whole Genome Sequencing Market Share by Region (2018-2033)
Figure 41. China Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 42. Japan Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 43. South Korea Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 45. India Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 46. Australia Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 47. Latin America Human Low-Pass Whole Genome Sequencing Market Share by Country (2018-2033)
Figure 48. Mexico Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 49. Brazil Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Share by Country (2018-2033)
Figure 51. Turkey Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 53. UAE Human Low-Pass Whole Genome Sequencing Market Size (2018-2033) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report